CALIFORNIA: Medical Marijuana, Inc., the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary HempMeds Brasil, in partnership with the Consulate General of Brazil in Houston, sponsored “Autism Together We Are Stronger” at Rice University on February 22.
“We see events like this one as prime opportunities to educate people on what cannabidiol, or CBD, is and its potential benefits,” said HempMeds® Brasil Vice President Caroline Heinz. “CBD can be legally imported in Brazil and is even subsidized by the Brazilian government for many indications including autism. We want to do everything we can to help bring awareness to current research that is being conducted on how CBD can be used by people around the world.”
In addition to sponsoring the event, HempMeds® Brasil shared the event stage with two researchers who the Company has worked with frequently in the past, Dr. Alysson Muotri, Professor at the School of Medicine, University of California in San Diego, and Dr. Abram Topczewski, Neuropediatrician and Enuresis Clinic Director at the Albert Einstein Hospital.
“Education is the most important thing when it comes to helping the world become more accepting of cannabis and its compounds,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “We’re proud to be able to sponsor events like these and work with such prestigious doctors such as Dr. Muotri and Dr. Topczewski to help further medical research around the world.”